Integrating the predominantly heart-specific expression of FHL2, its suggested antihypertrophic role and its lower expression in human heart failure, we hypothesized that FHL2 altered expression or genetic variants could be associated with HCM. The gene discussed is FHL2; the disease is heart failure.